Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
216 results found
Jul 21, 2020
Presentation
COVID-19
Progress with the Full Length Recombinant Spike Protein Nanoparticle Vaccine

2nd ISV COVID-19 Vaccines Virtual Congress

View/Download
Jun 27, 2020
Publication
Novavax led
The Journal of Infectious Diseases
RSV
Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection
Tseng, Hung Fu, Sy, Lina S., Ackerson, Bradley, et al.
View
Jun 23, 2020
Presentation
RSV
Learnings from a Phase 3 RSV Clinical Trial

New York Academy of Sciences: Innovations in Maternal, Neonatal, and Early Infancy Vaccines

Glenn, Gregory
View/Download
Jun 17, 2020
Publication
Novavax included/third party
Health Security
COVID-19, Matrix-M® adjuvant
Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks
Billington J, Deschamps I, Erck SC, et al.
View
May 10, 2020
Publication
Novavax led
Influenza and Other Respiratory Viruses
RSV
Prediction of serious RSV-related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons
Kieke, Burney A., Belongia, Edward A., McClure, David L., et al.
View
Mar 24, 2020
Presentation
Seasonal influenza
NanoFlu Phase 3 Topline Data
View/Download
Feb 22, 2020
Publication
Novavax led
Vaccine
Seasonal influenza
Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
Portnoff, Alyse D., Patel, Nita , Massare, Michael J., et al.
View
Sep 1, 2019
Presentation
Seasonal influenza
Induction of broadly cross-reactive immune responses against A(H3N2) viruses: results of a phase 2 trial of a novel recombinant hemagglutinin saponin-adjuvanted nanoparticle influenza vaccine (“NanoFlu”)

OPTIONS X for the Control of Influenza Conference

Shinde, Vivek
View/Download
Sep 1, 2019
Presentation
Seasonal influenza
Towards an Improved Wild-type Sequence Based Hemagglutination Inhibition Assay (HAI) for the Evaluation of Influenza Vaccines: Challenges and New Developments

OPTIONS X for the Control of Influenza Conference

Shinde, Vivek
View/Download
Aug 8, 2019
Presentation
RSV
Safety of Third Trimester Immunization with a Respiratory Syncytial Virus (RSV) F Protein Vaccine and Protection of Infants over the First 180 Days of Life Against All-Cause Lower Respiratory Tract Infection

Infectious Diseases Society for Obstetrics and Gynecology

Swamy, Geeta K.
View/Download